![]() |
|
|
2 Center for Infant Nutrition, Division of Neonatology, Macedonio Melloni Hospital, Milan 20129, Italy; 3 Sophia Children's Hospital, Erasmus University, Rotterdam 3015 GE, The Netherlands; and 4 Numico Research, Friedrichsdorf 61381, Germany
* To whom correspondence should be addressed. E-mail: asertac{at}tiscali.it.
A mixture of neutral short chain galactooligosaccharides and long chain fructo-oligosaccharides (scGOS/lcFOS) has been shown to have prebiotic and immunomodulatory effects comparable to human milk oligosaccharides. This can be translated into clinical practice as a potential to prevent infections and allergy. The hypothesis of this study was that this specific prebiotic mixture could have a preventive effect against infections during the first 6 mo of life. In a prospective, randomized, double-blind, placebo-controlled trial, healthy term infants with a parental history of atopy were fed either prebiotic-supplemented (8 g/L scGOS/lcFOS) or placebo-supplemented (8 g/L maltodextrin) hypoallergenic formula during the first 6 mo of life. The primary outcome measures were infectious episodes, number of infections requiring antibiotics, and incidence of infections. During the study period, infants in the scGOS/lcFOS group had fewer episodes of all types of infections combined (P = 0.01). They also tended to have fewer upper respiratory tract infection episodes (P = 0.07) and fewer infections requiring antibiotic treatment (P = 0.10). Similarly, the cumulative incidence of recurring infections was significantly lower in the scGOS/lcFOS group. The cumulative incidence of any recurring infection and recurring respiratory infections was 3.9 and 2.9% in the scGOS/lcFOS group and 13.5 and 9.6% in the placebo group, respectively (P < 0.05). Oligosaccharide prebiotics reduced the number of infectious episodes and the incidence of recurring, particularly respiratory, infections during the first 6 mo of life. Although the exact mechanism of action is under investigation, it is very likely that the immune modulating effect of this prebiotic mixture through intestinal flora modification is the principal mechanism for the observed infection prevention early in life.
This article has been cited by other articles:
![]() |
R. J. Joeckel and S. K. Phillips Overview of Infant and Pediatric Formulas Nutr Clin Pract, June 1, 2009; 24(3): 356 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Klaassens, R. J. Boesten, M. Haarman, J. Knol, F. H. Schuren, E. E. Vaughan, and W. M. de Vos Mixed-Species Genomic Microarray Analysis of Fecal Samples Reveals Differential Transcriptional Responses of Bifidobacteria in Breast- and Formula-Fed Infants Appl. Envir. Microbiol., May 1, 2009; 75(9): 2668 - 2676. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. J. Searle, A. Best, A. Nunez, F. J. Salguero, L. Johnson, U. Weyer, A. H. Dugdale, W. A. Cooley, B. Carter, G. Jones, et al. A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice J. Med. Microbiol., January 1, 2009; 58(1): 37 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Boehm and G. Moro Structural and Functional Aspects of Prebiotics Used in Infant Nutrition J. Nutr., September 1, 2008; 138(9): 1818S - 1828S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Grathwohl Early Supplementation of Prebiotic Oligosaccharides Protects Formula-Fed Infants against Infections during the First Six Months of Life J. Nutr., August 1, 2008; 138(8): 1520 - 1520. [Full Text] [PDF] |
||||
![]() |
S. Arslanoglu, G. E. Moro, and G. Boehm Reply to Dr. Grathwohl J. Nutr., August 1, 2008; 138(8): 1521 - 1521. [Full Text] [PDF] |
||||
![]() |
S. Arslanoglu, G. E. Moro, J. Schmitt, L. Tandoi, S. Rizzardi, and G. Boehm Early Dietary Intervention with a Mixture of Prebiotic Oligosaccharides Reduces the Incidence of Allergic Manifestations and Infections during the First Two Years of Life J. Nutr., June 1, 2008; 138(6): 1091 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. M. J. Scholtens, P. Alliet, M. Raes, M. S. Alles, H. Kroes, G. Boehm, L. M. J. Knippels, J. Knol, and Y. Vandenplas Fecal Secretory Immunoglobulin A Is Increased in Healthy Infants Who Receive a Formula with Short-Chain Galacto-Oligosaccharides and Long-Chain Fructo-Oligosaccharides J. Nutr., June 1, 2008; 138(6): 1141 - 1147. [Abstract] [Full Text] [PDF] |
||||